Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China · Delayed Price · Currency is CNY 14.08
+0.21 (1.51%)
Sep 30, 2026, 3:04 PM CST
SHE:002393 Revenue
Tianjin Lisheng Pharmaceutical had revenue of 309.35M CNY in the quarter ending June 30, 2026, a decrease of -14.47%. This brings the company's revenue in the last twelve months to 1.30B, down -1.58% year-over-year. In the year 2025, Tianjin Lisheng Pharmaceutical had annual revenue of 1.39B with 4.18% growth.
Revenue (ttm)
1.30B
Revenue Growth
-1.58%
P/S Ratio
3.33
Revenue / Employee
811.30K
Employees
1,605
Market Cap
4.34B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.39B | 55.86M | 4.18% |
| Dec 31, 2024 | 1.34B | 183.12M | 15.88% |
| Dec 31, 2023 | 1.15B | 6.44M | 0.56% |
| Jan 1, 2023 | 1.15B | 54.65M | 5.00% |
| Jan 1, 2022 | 1.09B | -48.90M | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jianmin Pharmaceutical Group | 3.18B |
| Jiangsu Lianhuan Pharmaceutical | 3.00B |
| Hunan Fangsheng Pharmaceutical | 1.87B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.73B |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 1.33B |
| Hunan Hansen Pharmaceutical | 1.01B |
| LanZhou Foci Pharmaceutical | 926.49M |
| Newland Pharmaceutical | 710.55M |